Pei-ning Hsu is a Chicago, Illinois based neurologist who is specialized in Neurology. Active license number of Pei-ning Hsu is 036170357 for Neurology in Illinois. Her current practice location is 5841 S Maryland Ave, Chicago. Patients can reach her at 888-824-0200. Pei-ning Hsu NPI number (Unique professional ID assigned by NPPES) is 1437775327. Pei-ning Hsu specializes in the diagnosis and treatment of diseases or impaired function of the brain, spinal cord, peripheral nerves, muscles, autonomic nervous system, and blood vessels that relate to these structures.
Complete Profile:
Pei-ning Hsu speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
Name:
Pei-ning Hsu
Specialization:
Neurology
Gender:
Female
Practice Address:
5841 S Maryland Ave, Chicago, Illinois, 60637-1443
Phone:
888-824-0200
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1437775327
NPI Enumeration Date:
17 Jun, 2020
NPI Last Update On:
24 Sep, 2025
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Pei-ning Hsu are as mentioned below.
License Number
Specialization
State
Status
036170357
Neurology
Illinois
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Pei-ning Hsu 600 S Paulina St Ste 403, Chicago, Illinois
Zip:
60612-3806
Patients can reach Pei-ning Hsu at 5841 S Maryland Ave, Chicago, Illinois or can call to book an appointment on 888-824-0200.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 13 October, 2025.